Inventor · disambiguated record
Mark G. Saulnier
Also filed as: SAULNIER MARK · SAULNIER MARK G · SAULNIER MARK GEORGE
41 granted patents·9 pending applications·1,322 citations·filing 1987–2025
98Inventor score
Files withBRISTOL MYERS SQUIBB CO16AVILAR THERAPEUTICS INC10BRISTOL MYERS CO10STABLIX INC4VIIV HEALTHCARE UK NO 5 LTD4
Top patents by PatentIndex Score
50 records- 0198US4975278AAntibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cellsBRISTOL MYERS CO·Filed 1988·Granted Dec 4, 1990·1k cites·64 claims
- 0296US11819551B2ASGPR-binding compounds for the degradation of extracellular proteinsAVILAR THERAPEUTICS INC·Filed 2022·Granted Nov 21, 2023·10 cites·30 claims
- 0395US5041424AEpipodophyllotoxin glucoside 4'-phosphate derivativesBRISTOL MYERS CO·Filed 1989·Granted Aug 20, 1991·68 cites·2 claims
- 0494US7534792B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 19, 2009·30 cites·14 claims
- 0593US7223757B2Tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 29, 2007·16 cites·21 claims
- 0690US10954252B1Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2018·Granted Mar 23, 2021·6 cites·11 claims
- 0789US12290568B2ASGPR-binding compounds for the degradation of extracellular proteinsAVILAR THERAPEUTICS INC·Filed 2024·Granted May 6, 2025·1 cites·30 claims
- 0889US12280116B2ASGPR-binding compounds for the degradation of extracellular proteinsAVILAR THERAPEUTICS INC·Filed 2024·Granted Apr 22, 2025·1 cites·30 claims
- 0989US7879855B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Feb 1, 2011·10 cites·1 claims
- 1088US12128106B2ASGPR-binding compounds for the degradation of extracellular proteinsAVILAR THERAPEUTICS INC·Filed 2024·Granted Oct 29, 2024·1 cites·5 claims
- 1188US4904768AEpipodophyllotoxin glucoside 4'-phosphate derivativesBRISTOL MYERS CO·Filed 1988·Granted Feb 27, 1990·37 cites·31 claims
- 1287US10144706B2Compounds useful as immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Dec 4, 2018·7 cites·8 claims
- 1386US12312340B2Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteinsAVILAR THERAPEUTICS INC·Filed 2024·Granted May 27, 2025·0 cites·11 claims
- 1486US11505543B24-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Granted Nov 22, 2022·3 cites·4 claims
- 1583US2025339541A1Asgpr-binding compounds for the degradation of extracellular proteinsAVILAR THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1682US12091402B2Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteinsAVILAR THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·0 cites·29 claims
- 1781US2025213699A1Asgpr-binding compounds for the degradation of extracellular proteinsAVILAR THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1879US10745382B2Compounds useful as immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 18, 2020·2 cites·25 claims
- 1979US8445676B2Pyrrolotriazine kinase inhibitorsPURANDARE ASHOK VINAYAK·Filed 2009·Granted May 21, 2013·5 cites·10 claims
- 2078USRE35524EEpipodophyllotoxin glucoside 4'-phosphate derivativesBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Jun 3, 1997·27 cites·23 claims
- 2177US10590105B21,3-dihydroxy-phenyl derivatives useful as immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 17, 2020·2 cites·8 claims
- 2276US2025223280A1Potent asgpr-binding compounds for the degradation of immunoglobulins and other proteinsAVILAR THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2374US7081454B2Tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jul 25, 2006·6 cites·20 claims
- 2473US12076408B2ASGPR-binding compounds for the degradation of extracellular proteinsAVILAR THERAPEUTICS INC·Filed 2023·Granted Sep 3, 2024·0 cites·26 claims
- 2570US4965348ADimeric epipodophyllotoxin glucoside derivativesBRISTOL MYERS CO·Filed 1989·Granted Oct 23, 1990·16 cites·10 claims
- 2669US9266880B2Substituted azaindazole compoundsAUSTIN JOEL F·Filed 2011·Granted Feb 23, 2016·2 cites·13 claims
- 2767US8916553B2Sulfonamide compounds useful as CYP17 inhibitorsAUSTIN JOEL FRANCIS·Filed 2011·Granted Dec 23, 2014·2 cites·14 claims
- 2866US6677450B2Topoisomerase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jan 13, 2004·3 cites·9 claims
- 2964US6686385B2Anhydro sugar derivatives of indolocarbazolesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 3, 2004·1 cites·24 claims
- 3064US4935504AEpipodophyllotoxin glucoside 4'-acyl derivativesBRISTOL MYERS CO·Filed 1988·Granted Jun 19, 1990·13 cites·43 claims
- 3163US6610727B2Anhydro sugar derivatives of indolocarbazolesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Aug 26, 2003·1 cites·12 claims
- 3263US2025127907A1Parp inhibitorsSTABLIX INC·Filed 2024·Application pending·0 cites
- 3363US2025171465A1Akt inhibitorsSTABLIX INC·Filed 2024·Application pending·0 cites
- 3460US6855698B2Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazolesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Feb 15, 2005·1 cites·45 claims
- 3560US4888419A3'-demethoxyepipodophyllotoxin glucoside derivativesBRISTOL MYERS CO·Filed 1987·Granted Dec 19, 1989·9 cites·4 claims
- 3659US4868291A4'-deshydroxyepipodophyllotoxin glucosides: synthesis and useBRISTOL MYERS CO·Filed 1987·Granted Sep 19, 1989·8 cites·12 claims
- 3759US2025282783A1Protein stabilizing compounds containing usp28 and/or usp25 targeting ligandsSTABLIX INC·Filed 2022·Application pending·0 cites
- 3858US2024358842A1Protein stabilizing compounds containing usp7 ligandsSTABLIX INC·Filed 2022·Application pending·0 cites
- 3957US4916217APhosphorus containing derivatives of epipodophyllotoxinBRISTOL MYERS CO·Filed 1987·Granted Apr 10, 1990·9 cites·10 claims
- 4056US8592579B2Pyrrolotriazine kinase inhibitorsWITTMAN MARK D·Filed 2012·Granted Nov 26, 2013·0 cites·1 claims
- 4156US4874851A3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivativesBRISTOL MYERS CO·Filed 1987·Granted Oct 17, 1989·7 cites·18 claims
- 4255US4853467ANitrogen containing derivatives of epipodophyllotoxin glucosidesBRISTOL MYERS CO·Filed 1987·Granted Aug 1, 1989·7 cites·59 claims
- 4354US9187434B2Substituted 1,5-benzodiazepinones compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 17, 2015·0 cites·9 claims
- 4450US9775831B2Combinations comprising biphenyl derivatives for use in the treatment of HCVBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 3, 2017·0 cites·12 claims
- 4546US10617675B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 14, 2020·0 cites·9 claims
- 4646US9427442B2Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 30, 2016·0 cites·7 claims
- 4741US2020016136A1Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2018·Application pending·0 cites
- 4840US2020055839A1Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2018·Application pending·0 cites
- 4938US8673922B2Azaindazole compoundsVELAPARTHI UPENDER·Filed 2011·Granted Mar 18, 2014·0 cites·8 claims
- 5036US9169295B2Macrocycles and macrocycle stabilized peptidesSAULNIER MARK G·Filed 2011·Granted Oct 27, 2015·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →